Uso de la cefalexina en infecciones piogenas de la piel: comparacion de dos esquemas terapeuticos

Página do item simplificado
dc.contributor.authorDillon, N. Lima
dc.contributor.authorCampos, P. C. E. Oliveira de
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-26T16:04:23Z
dc.date.available2014-05-26T16:04:23Z
dc.date.issued1979-01-01
dc.description.abstract50 patients with pyogenic infections of the skin were divided into 2 groups and treated with cephalexin. Group A, 26 patients, received 500 mg/12 hours; Group B, 24 patients, 250 mg/6 hours. Clinical diagnosis was substantiated by bacteriologic study of cultures to identify the organism and determination of its susceptibility to the drug. Group A showed 91%, group B 95%; satisfactory results. No side-effects were noted. Either form of dosage was effective in the treatment of pyogenic infections of the skin.en
dc.format.extent40-47
dc.identifierhttp://www.bago.com/bago/bagoarg/biblio/septweb03.htm
dc.identifier.citationInvestigacion Medica Internacional, v. 6, n. SUPPL. 1, p. 40-47, 1979.
dc.identifier.issn0185-2108
dc.identifier.scopus2-s2.0-0018386510
dc.identifier.urihttp://hdl.handle.net/11449/63445
dc.language.isospa
dc.relation.ispartofInvestigacion Medica Internacional
dc.rights.accessRightsAcesso aberto
dc.sourceScopus
dc.subjectcefalexin
dc.subjectacne
dc.subjectdermatitis
dc.subjectdrug dose
dc.subjectdrug therapy
dc.subjectimpetigo
dc.subjectpyoderma
dc.subjectskin infection
dc.subjecttherapy
dc.titleUso de la cefalexina en infecciones piogenas de la piel: comparacion de dos esquemas terapeuticoses
dc.title.alternativeCephalexin in pyogenic infections of the skin: comparison of two therapeutic regimensen
dc.typeArtigo

Arquivos

Coleções

Artigos